相关实验视频

Updated: Apr 13, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

在和结构性研究中,硫胺针对甲基耐药黄金葡萄球菌的VraSR两组系统

Abhishek Kumar Verma¹, Sandeep Kumar Srivastava¹

¹Structural Biology & Bioinformatics Laboratory, Department of Biosciences, Manipal University Jaipur, Jaipur, Rajasthan, India.

Journal of biomolecular structure & dynamics

|February 6, 2024

概括

抗药性黄金葡萄球菌菌株构成了全球威胁. 这项研究确定了针对VraSR双组分系统的新型硫胺衍生物,为抗生素耐药性感染提供了潜在的新疗法.

科学领域:

微生物学微生物学
计算化学计算化学
药物发现药物发现药物发现

背景情况:

耐药黄金菌 (Staphylococcus aureus) 是一个重要的全球健康问题.
这种VraSR双组分系统 (TCS),由基因酶VraS和响应调节器VraR调节,对于*S. aureus*对细胞壁向抗生素的耐药性至关重要.
硫胺衍生物已经显示出对黄金菌感染的有效性,特别是在耐甲林菌株中.

研究的目的:

通过使用计算方法,识别针对*S. aureus*中VraSR TCS的强硫胺衍生物抑制剂.
评估已识别的化合物与VraS和VraR成分的结合亲和力和相互作用.
探索针对抗生素耐药性黄金菌的新型治疗策略.

主要方法:

针对VraS和VraR的抗菌化合物库的基于基的虚拟查 (LBVS).
分子相互作用和结合能量的计算预测和模拟.
对已识别的硫胺衍生物的结合参数分析,包括ΔG_bind.

主要成果:

确定了一种有前途的硫胺衍生物,其结合能为-294.32 kJ/mol,对抗VraS ATP结合域.
四种化合物 (N1,N3,N9,N10) 对VraR DNA结合域表现出显著的结合能量,范围从-165.21到-237.54kJ/mol.
结构和模拟分析表明稳定的相互作用和VraR二分化的潜在干扰,表明DNA结合的抑制.

结论:

已识别的硫胺衍生物显示出作为S. aureus*中VraSR TCS的抑制剂的潜力.
这些化合物代表了开发新疗法剂的潜在线索,用于对抗耐药的金黄色菌株.
计算药物发现策略,包括LBVS和模拟,对于识别针对关键毒性因子的新型抗菌线索是有效的.

关键词:

药物耐药的金黄色细菌S.这就是VraRC VraRC.这是一个真正的问题.抗菌化合物库抗菌化合物库在片选中硫胺基衍生物的硫胺基衍生物两个组成部分的系统系统.

更多相关视频

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Published on: May 5, 2016

Atomic Force Microscopy Combined with Infrared Spectroscopy as a Tool to Probe Single Bacterium Chemistry

Atomic Force Microscopy Combined with Infrared Spectroscopy as a Tool to Probe Single Bacterium Chemistry

Published on: September 15, 2020

相关概念视频

Staphylococcal Skin Infections

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...